Roche Invests $50 Billion in U.S. Amid Tariff Concerns

To counter escalating tariffs, pharmaceutical giant Roche is investing $50 billion in the United States over the next five years. The investment will support expanding R&D facilities and manufacturing plants across multiple states, creating 12,000 new jobs in the process. This significant move reflects Roche’s commitment to bolstering its US operations amidst potential tariff impacts.